(Q82248971)
Statements
Dasatinib combined with interferon-alfa induces a complete cytogenetic response and major molecular response in a patient with chronic myelogenous leukemia harboring the T315I BCR-ABL1 mutation (English)
A Megan Cornelison
Mary-Alma Welch
Charles Koller